Skip to main content

Table 2 Clinical characteristics of GMPP and RMPP

From: Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia

Characteristics

GMPP (n = 51)

RMPP (n = 56)

P value

Age (y)

3.679 ± 3.193

4.805 ± 3.322

0.077

Gender (male/female)

27/51

28/56

0.847

Clinical presentation

 Wheezing, No. (%)

7(13.73)

13(23.21)

0.227

 Hypoxemia, No. (%)

4(7.84)

12(21.43)

0.060

 Duration of fever (d)

4.784 ± 2.831

10.339 ± 6.473

< 0.001

 Duration of wheezing (d)

0.00(0.00,5.00)

0.00(0.00,7.00)

0.459

 Extrapulmonary complications, No. (%)

6(11.76)

12(23.21)

0.137

Imaging features, No. (%)

 Consolidation, No. (%)

22(43.14)

37(66.07)

0.02

 Interstitial changes, No. (%)

26(50.98)

16(28.57)

0.029

Laboratory detection

 White blood cell count (*109/L)

9.583 ± 3.348

8.420 ± 3.530

0.084

 Lymphocyte percentage (%)

37.291 ± 14.817

32.352 ± 14.690

0.088

 C-reactive protein (mg/l)

12.00(8.00,25.00)

11.00(5.00,25.75)

0.664

 ESR (mm/h)

29.11 ± 19.935

37.88 ± 22.412

0.045

 Coinfection, No. (%)

28(54.90)

32(57.14)

0.847

 Coinfection with adenovirus, No. (%)

6(11.76)

18(32.14)

0.019

 A2063G mutation, No. (%)

20(39.22)

40(71.43)

0.001

Treatment

 No fever within 48 h after application of macrolides, No. (%)

6(11.76)

50(89.29)

< 0.001

 Application of glucocorticoids, No. (%)

24(47.06)

44(78.57)

0.001

 Mechanical ventilation, No. (%)

4(7.84)

3(5.36)

0.707

  1. Data are No. (%) of patients, mean ± standard deviation (SD) or median (interquartile range)
  2. Abbreviation: General Mycoplasma pneumoniae pneumonia (GMPP); refractory Mycoplasma pneumoniae pneumonia (RMPP)